Free Trial

Gemini Therapeutics (GMTX) Stock Trends and Sentiment

$1.35
-37.81 (-96.55%)
(As of 12/29/2022)

Media Mentions Over Time

Page Views Over Time



Recieve Gemini Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter.

GMTX Social Media Mentions

Related Companies and Tools

This page (NASDAQ:GMTX) was last updated on 6/17/2024 by MarketBeat.com Staff

From Our Partners